Page last updated: 2024-08-24

topotecan and stilbenes

topotecan has been researched along with stilbenes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobberstein, KU; QuiƱones, A; Rainov, NG1
Beijnen, JH; Borst, P; Breedveld, P; Cipriani, G; Dahlhaus, F; de Wolf, CJ; Jansen, G; Kuil, A; Pluim, D; Scheffer, GL; Schellens, JH; van Eijndhoven, MA1
Martin, S1

Other Studies

3 other study(ies) available for topotecan and stilbenes

ArticleYear
The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells.
    Life sciences, 2003, May-16, Volume: 72, Issue:26

    Topics: Animals; Antineoplastic Agents; Cell Line; DNA; DNA Damage; DNA-Binding Proteins; Early Growth Response Protein 1; Gene Expression Regulation; Genes, Reporter; Humans; Immediate-Early Proteins; MAP Kinase Signaling System; Mitomycin; Mutagens; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; Resveratrol; Stilbenes; Topotecan; Transcription Factors; Tumor Suppressor Protein p53; Zinc Fingers

2003
The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models.
    Molecular pharmacology, 2007, Volume: 71, Issue:1

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Line; Cell Line, Tumor; Dogs; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Liver; Methotrexate; Mitoxantrone; Neoplasm Proteins; Rabbits; Resveratrol; Stilbenes; Topotecan

2007
New Agents in Clinical Oncology. 24 November 2006, London, UK.
    IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:2

    Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bibenzyls; Combined Modality Therapy; Enzyme Inhibitors; Humans; Medical Oncology; Neoplasms; Norepinephrine Plasma Membrane Transport Proteins; Poly(ADP-ribose) Polymerase Inhibitors; Proteomics; Stilbenes; Thioredoxins; Topotecan

2007